CD40LG and cancer: Vardouli et al. [99] assessed the effect of therapy using recombinant non-replicating adenovirus, showing the expression of CD40L, replication-defective recombinant adenovirus (RAd)-hCD40L (RAd vector expressing hCD40L) on cancer cells.